584 related articles for article (PubMed ID: 3309510)
1. Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system.
Säynävälammi P; Pörsti I
Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):325-31. PubMed ID: 3309510
[TBL] [Abstract][Full Text] [Related]
2. Effects of two structurally different angiotensin-converting enzyme inhibitors, captopril and quinapril (CI-906), in rats with one-kidney deoxycorticosterone-salt hypertension.
Pörsti I; Säynävälammi P; Arvola P; Nurmi AK; Manninen V; Ylitalo P; Vapaatalo H
Methods Find Exp Clin Pharmacol; 1986 Sep; 8(9):543-6. PubMed ID: 3022083
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of angiotensin-converting enzyme with quinapril (CI-906): investigation of antihypertensive mechanisms in spontaneously hypertensive rats.
Säynävälammi P; Pörsti I; Nurmi AK; Seppälä E; Metsä-Ketelä T; Tuomisto L; Manninen V; Vapaatalo H
J Pharmacol Exp Ther; 1986 Apr; 237(1):246-51. PubMed ID: 3007740
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
De Godoy MA; Rattan S
J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
[TBL] [Abstract][Full Text] [Related]
6. Effects of quinapril, a new angiotensin-converting enzyme inhibitor, on vasoconstrictor activity in the isolated, perfused mesenteric vasculature of hypertensive rats.
Major TC; Overhiser RW; Taylor DG; Panek RL
J Pharmacol Exp Ther; 1993 Apr; 265(1):187-93. PubMed ID: 8474005
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibition attenuates arterial constrictor responses in experimental hypertension.
Kähönen M; Mäkynen H; Wu X; Arvola P; Pekki A; Pörsti I
J Pharmacol Exp Ther; 1996 Jun; 277(3):1701-9. PubMed ID: 8667241
[TBL] [Abstract][Full Text] [Related]
8. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
[TBL] [Abstract][Full Text] [Related]
9. Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats.
Hu WY; Chen DG; Chen SC; Jin XQ; Wang HJ
Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):507-12. PubMed ID: 9863143
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
[TBL] [Abstract][Full Text] [Related]
11. Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics.
Chan PS; Ronsberg MA; Cervoni P
Fed Proc; 1984 Apr; 43(5):1346-50. PubMed ID: 6200364
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z
Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
[TBL] [Abstract][Full Text] [Related]
13. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a functional tissue renin-angiotensin system in the rat mesenteric vasculature and its involvement in regulating blood pressure.
Weishaar RE; Panek RL; Major TC; Simmerman J; Rapundalo ST; Taylor DG
J Pharmacol Exp Ther; 1991 Feb; 256(2):568-74. PubMed ID: 1847201
[TBL] [Abstract][Full Text] [Related]
15. CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors.
Kaplan HR; Cohen DM; Essenburg AD; Major TC; Mertz TE; Ryan MJ
Fed Proc; 1984 Apr; 43(5):1326-9. PubMed ID: 6323223
[TBL] [Abstract][Full Text] [Related]
16. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
Guidi E; Hollenberg NK
J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive activity of alacepril in spontaneously hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats and dogs.
Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
Arzneimittelforschung; 1985; 35(10):1507-12. PubMed ID: 3000390
[TBL] [Abstract][Full Text] [Related]
20. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]